Poultry healthcare market seen reaching $14.87 billion by 2030

By AI, Created 9:48 AM UTC, May 20, 2026, /AGP/ – The poultry healthcare market is projected to grow from $9.29 billion in 2025 to $14.87 billion by 2030, driven by rising poultry consumption, disease management needs and demand for antibiotic-free products. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Poultry healthcare is becoming more central to food supply as poultry production expands and disease risks rise in larger flocks. - The market’s growth points to stronger demand for vaccines, diagnostics, supplements and biosecurity tools across poultry operations. - The shift toward antibiotic-free poultry products could accelerate adoption of alternative health management approaches.

What happened: - The Business Research Company released its Poultry Healthcare Global Market Report 2026 – Market Size, Trends, And Forecast 2026–2030 on May 5, 2026. - The report projects the poultry healthcare market will rise from $9.29 billion in 2025 to $10.22 billion in 2026. - The market is forecast to reach $14.87 billion by 2030. - The report pegs the market’s forecast-period CAGR at 9.8%. - North America held the largest regional share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - Poultry healthcare covers services that maintain the health and wellbeing of domesticated birds such as chickens, turkeys, ducks, geese and quail. - The scope includes removing sick birds from flocks, administering vaccinations, managing healthcare resources and overseeing cleanliness, feeding schedules and housing conditions. - Past growth was driven by higher poultry production, bacterial and viral infections, traditional antibiotic use for growth promotion, limited biosecurity awareness and more laboratory testing for poultry diseases. - Forecast growth is expected to come from demand for antibiotic-free poultry products, wider use of precision medicine and vaccines, more nutritional supplements and feed additives, and expansion of molecular diagnostics and ELISA testing. - Investment in poultry healthcare infrastructure and biosecurity practices is also expected to support growth. - Reported trends include greater use of live attenuated and recombinant vaccines, rising demand for probiotics and prebiotics in poultry feed, and more frequent molecular diagnostic testing for disease identification. - The report also cites improved farm hygiene and greater awareness of alternatives to antibiotic growth promoters. - The market analysis covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report provides a free sample and a full report.

Between the lines: - Rising poultry consumption is pushing farmers to manage bigger flocks, which increases exposure to infectious disease and makes preventative healthcare more valuable. - The strong forecast for diagnostics and vaccines suggests the industry is moving from reactive treatment toward prevention and monitoring. - The split between North American leadership and Asia-Pacific growth suggests mature markets are consolidating while production expansion is shifting demand toward faster-growing regions.

What’s next: - The report expects continued adoption of molecular diagnostics, ELISA testing, vaccines and feed additives through 2030. - Biosecurity spending and farm hygiene improvements are likely to remain key areas of investment as producers respond to disease pressure and consumer demand. - The market’s trajectory will likely track poultry consumption trends and the pace of antibiotic reduction across major producing regions.

The bottom line: - Poultry healthcare is moving from a niche animal-health category to a growth market tied directly to food production, disease prevention and antibiotic alternatives.